SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

Where will US markets find their bottom? A model points to a potential 11% drop

Matrix looks to Wall Street: $2.1 billion merger could pave way for Nasdaq listing

IAI reports record $6.1 billion in sales as global demand for weapons surges

Buzz

Most popular

Daily

Weekly

1

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

2

"Eventually, AI will surpass us in everything"—so what skills will still matter?

3

Cyber unicorn Pentera raises $60M at over $1B valuation as ARR approaches $100M

4

QuamCore raises $9 million in Seed funding to build scalable 1 million qubit quantum computer

5

Sola Security aims to be the Wix of cyber with $30 million Seed round

Michael Levitt

3 stories about Michael Levitt

מייקל לויט פרופסור חתן פרס נובל ל כימיה

Take it or Levitt: A Nobel Prize winner’s winding road to the top

09.02.25|Roni Dori

Prof. Michael Levitt talks about his unconventional life path, from childhood in South Africa with a single mother, emigrating to England, and finding logic in the chaos of nature.

מוסף שבועי 12.03.20 קורנה במגמת בלימה מייקל לויט

Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive

13.03.20|Ari Libsker

Nobel laureate and Stanford professor of Biology assures Israelis: statistics show the virus is on a downturn. Read more!

מוסף שבועי 18.7.19 ד"ר שחר ברבש

Paving the Way to Alzheimer’s Cure, One Algorithm at a Time

19.07.19|Tzipi Smilovitz

Israeli scientist Shahar Barbash is making waves in the pharmaceutical world with a new approach to image analysis that has even chemistry Nobel laureate Michael Levitt on board